[Webinar] Securing Business Benefits Beyond Serialization
How to leverage your anti-counterfeiting investment to achieve value beyond compliance
Avi Chaudhuri, PhD, Chief Scientist at Systech will share how you can drive greater business value, increase patient safety and protect your brand
The global value of pharmaceutical counterfeiting is $200B annually. More staggering is that the grey market is forecasted to reach almost $3 trillion by 2022.
Serialization is a great achievement for the pharmaceutical industry. However, most executives now realize it has fallen short of the end goal—to protect people from the dangers of pharmaceutical counterfeiting and diversion.
It’s become clear that serialization is only part of the solution and cannot alone solve this global problem.
Serialization is simply the end of the beginning.
As compliance mandates evolve and counterfeiters become more sophisticated, more time and effort will be required to meet these global challenges.
But is it possible to gain significant value beyond serialization without major upgrades and investments?
Can you actually leverage your existing investment for greater value, increased patient safety and ongoing brand protection?
In this Webinar, Avi Chaudhuri, PhD will discuss:
- Why we need to look beyond serialization and understand the real risks to consumers, brand reputation and your bottom line.
- How to leverage existing package labelling with non-additive security, e-Fingerprinting and “smart packaging”
- Cost effective solutions to prevent counterfeiting and diversion being used by the industry today
- How to stay innovative and add value to consumers with mobile and engagement programs
- Why patient adherence data and analytics could help your organization gain a competitive advantage
Sign up now to secure your place!
Find out more about our expert:
Avi Chaudhuri, PhD
Chief Scientist, Systech
Dr. Avi Chaudhuri has nearly fifteen years of experience in brand protection. His work in this field began in 2004 when he himself became the victim of a counterfeit drug. At that point, he began to research all available technologies that could not only defeat this problem, but also empower consumers to verify the genuineness of the drug right at the point of sale.
Dr. Chaudhuri spearheads Systech’s brand protection technological development and expansion. In his role, Dr. Chaudhuri is responsible for harnessing and evolving Systech’s tech potential to enable our customers to fight the ongoing threat of counterfeiting.
Prior to joining Systech, Dr. Chaudhuri designed and deployed serialization, traceability and brand protection programs for some of the largest companies in the world. Additionally, he introduced the concept of mass serialization to the Indian pharmaceutical industry, allowing patients to authenticate their drug purchases via a national SMS program. He has also authored several manuscripts and white papers on technology solutions to combat counterfeiting which have had significant impact on shaping public policy and protecting consumers.
Dr. Chaudhuri holds a Ph.D. in neuroscience from the University of California, Berkeley. In addition to his work at Systech, he is the founder and trustee of the Purnima Foundation in India.